SCHEMBL4151779

SCHEMBL4151779

Cc1c(NC(=O)c2cccnc2)cccc1-c1cn2ccnc2c(Nc2ccc(CN3CCOCC3)cc2)n1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BTK Q06187 17/20 0.56
AURKA O14965 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1068234 0.89 BTK (0.63) BTK
SCHEMBL1071096 0.89 BTK (0.61) BTK
SCHEMBL5280971 0.89 BTK (0.70) BTK
SCHEMBL5275203 0.88 BTK (0.54) BTK
SCHEMBL1068707 0.81 SYK (0.53) BTKAURKA
SCHEMBL3345737 0.80 BTK (0.53) BTK
SCHEMBL5242557 0.80 BTK (0.64) BTK
SCHEMBL5918869 0.79 BTK (0.62) BTK
SCHEMBL5240831 0.79 BTK (0.78) BTK
SCHEMBL1070103 0.78 BTK (0.76) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2068849-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI Pharmaceuticals, Inc. (US) 2009-06-17 EP disclosed
WO-2008033858-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2008-03-20 WO disclosed